GlassScriptPhysician profile
Arlene V Bayreder
NPI 1659389062
$2,138.80
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $1,544 · 2023: $224 · 2024: $23.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Global Blood Therapeutics, INC. | $403.73 | 2021-2022 | |
| Genentech USA, INC. | $323.61 | 2021-2022 | |
| Novo Nordisk INC | $210.87 | 2022-2023 | Tretten, Novoeight, Rebinyn |
| Genentech, INC. | $183.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $160.37 | 2022-2023 | |
| Pfizer INC. | $124.54 | 2022-2024 | |
| Incyte Corporation | $110.82 | 2022 | |
| Bio Products Laboratory USA, INC. | $102.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $90.13 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.71 | 2021-2023 | Vonvendi |
| Genzyme Corporation | $70.49 | 2022 | |
| Biomarin Pharmaceutical INC. | $40.00 | 2022 | |
| Emmaus Medical, INC. | $39.38 | 2022-2023 | Endari |
| Merck Sharp & Dohme LLC | $35.63 | 2021 | |
| Supernus Pharmaceuticals, INC. | $28.58 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hema Biologics, LLC | $26.99 | 2022 | |
| Abiomed | $26.99 | 2022 | |
| Grifols USA, LLC | $23.94 | 2022 | |
| Duchesnay USA Incorporated | $21.71 | 2022 | |
| Chiesi USA, INC. | $16.83 | 2022 | |
| Kaleo, INC. | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Bayreder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.